IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0012647.html
   My bibliography  Save this article

Assessing the Performance of a Computer-Based Policy Model of HIV and AIDS

Author

Listed:
  • Chara E Rydzak
  • Kara L Cotich
  • Paul E Sax
  • Heather E Hsu
  • Bingxia Wang
  • Elena Losina
  • Kenneth A Freedberg
  • Milton C Weinstein
  • Sue J Goldie
  • for the CEPAC Investigators

Abstract

Background: Model-based analyses, conducted within a decision analytic framework, provide a systematic way to combine information about the natural history of disease and effectiveness of clinical management strategies with demographic and epidemiological characteristics of the population. Among the challenges with disease-specific modeling include the need to identify influential assumptions and to assess the face validity and internal consistency of the model. Methods and Findings: We describe a series of exercises involved in adapting a computer-based simulation model of HIV disease to the Women's Interagency HIV Study (WIHS) cohort and assess model performance as we re-parameterized the model to address policy questions in the U.S. relevant to HIV-infected women using data from the WIHS. Empiric calibration targets included 24-month survival curves stratified by treatment status and CD4 cell count. The most influential assumptions in untreated women included chronic HIV-associated mortality following an opportunistic infection, and in treated women, the ‘clinical effectiveness’ of HAART and the ability of HAART to prevent HIV complications independent of virologic suppression. Good-fitting parameter sets required reductions in the clinical effectiveness of 1st and 2nd line HAART and improvements in 3rd and 4th line regimens. Projected rates of treatment regimen switching using the calibrated cohort-specific model closely approximated independent analyses published using data from the WIHS. Conclusions: The model demonstrated good internal consistency and face validity, and supported cohort heterogeneities that have been reported in the literature. Iterative assessment of model performance can provide information about the relative influence of uncertain assumptions and provide insight into heterogeneities within and between cohorts. Description of calibration exercises can enhance the transparency of disease-specific models.

Suggested Citation

  • Chara E Rydzak & Kara L Cotich & Paul E Sax & Heather E Hsu & Bingxia Wang & Elena Losina & Kenneth A Freedberg & Milton C Weinstein & Sue J Goldie & for the CEPAC Investigators, 2010. "Assessing the Performance of a Computer-Based Policy Model of HIV and AIDS," PLOS ONE, Public Library of Science, vol. 5(9), pages 1-13, September.
  • Handle: RePEc:plo:pone00:0012647
    DOI: 10.1371/journal.pone.0012647
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012647
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0012647&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0012647?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Y. Yazdanpanah & E. Losina & X. Anglaret & S.J. Goldie & R.P. Walensky & M.C. Weinstein & S. Toure & H.E. Smith & J.E. Kaplan & K.A. Freedberg & For The Global Aids Policy Model Investigators, 2005. "Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Cote d'Ivoire: a trial-based analysis," Post-Print hal-00201936, HAL.
    2. Schackman, B.R. & Goldie, S.J. & Weinstein, M.C. & Losina, E. & Zhang, H. & Freedberg, K.A., 2001. "Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults," American Journal of Public Health, American Public Health Association, vol. 91(9), pages 1456-1463.
    3. S.J. Goldie & Y. Yazdanpanah & E. Losina & M.C. Weinstein & X. Anglaret & R.P. Walensky & H.E. Hsu & A. Kimmel & C. Holmes & J.E. Kaplan & K.A. Freedberg, 2006. "Cost-effectiveness of HIV treatment in Resource-Poor Settings - The case of Côte d'Ivoire," Post-Print hal-00199992, HAL.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ingrid V Bassett & Darshini Govindasamy & Alison S Erlwanger & Emily P Hyle & Katharina Kranzer & Nienke van Schaik & Farzad Noubary & A David Paltiel & Robin Wood & Rochelle P Walensky & Elena Losina, 2014. "Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness," PLOS ONE, Public Library of Science, vol. 9(1), pages 1-11, January.
    2. Bärnighausen, Till & Bloom, David E., 2009. ""Conditional scholarships" for HIV/AIDS health workers: Educating and retaining the workforce to provide antiretroviral treatment in sub-Saharan Africa," Social Science & Medicine, Elsevier, vol. 68(3), pages 544-551, February.
    3. Kartik K Venkatesh & Jessica E Becker & Nagalingeswaran Kumarasamy & Yoriko M Nakamura & Kenneth H Mayer & Elena Losina & Soumya Swaminathan & Timothy P Flanigan & Rochelle P Walensky & Kenneth A Free, 2013. "Clinical Impact and Cost-Effectiveness of Expanded Voluntary HIV Testing in India," PLOS ONE, Public Library of Science, vol. 8(5), pages 1-11, May.
    4. Lasserre, Pierre & Moatti, Jean-Paul & Soubeyran, Antoine, 2006. "Early initiation of highly active antiretroviral therapies for AIDS: Dynamic choice with endogenous and exogenous learning," Journal of Health Economics, Elsevier, vol. 25(3), pages 579-598, May.
    5. Damon, Maria & Zivin, Joshua Graff & Thirumurthy, Harsha, 2015. "Health shocks and natural resource management: Evidence from Western Kenya," Journal of Environmental Economics and Management, Elsevier, vol. 69(C), pages 36-52.
    6. Michael Kremer & Christopher M. Snyder, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 53(1), pages 235-273, August.
    7. Romain Micol & Ayden Tajahmady & Olivier Lortholary & Suna Balkan & Catherine Quillet & Jean-Philippe Dousset & Hak Chanroeun & Yoann Madec & Arnaud Fontanet & Yazdan Yazdanpanah, 2010. "Cost-Effectiveness of Primary Prophylaxis of AIDS Associated Cryptococcosis in Cambodia," PLOS ONE, Public Library of Science, vol. 5(11), pages 1-8, November.
    8. Lauren M Uhler & Nagalingeswaran Kumarasamy & Kenneth H Mayer & Anjali Saxena & Elena Losina & Malaisamy Muniyandi & Adam W Stoler & Zhigang Lu & Rochelle P Walensky & Timothy P Flanigan & Melissa A B, 2010. "Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India," PLOS ONE, Public Library of Science, vol. 5(9), pages 1-9, September.
    9. April D. Kimmel & Daniel W. Fitzgerald & Jean W. Pape & Bruce R. Schackman, 2015. "Performance of a Mathematical Model to Forecast Lives Saved from HIV Treatment Expansion in Resource-Limited Settings," Medical Decision Making, , vol. 35(2), pages 230-242, February.
    10. James G Kahn & Nicholas Muraguri & Brian Harris & Eric Lugada & Thomas Clasen & Mark Grabowsky & Jonathan Mermin & Shahnaaz Shariff, 2012. "Integrated HIV Testing, Malaria, and Diarrhea Prevention Campaign in Kenya: Modeled Health Impact and Cost-Effectiveness," PLOS ONE, Public Library of Science, vol. 7(2), pages 1-9, February.
    11. Juan J. DelaCruz, 2018. "Foreign Aid and HIV/AIDS in Latin America and the Caribbean: Should We Adjust the Degree of Response?," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 46(3), pages 337-349, September.
    12. Nicolas A Menzies & Andres A Berruti & John M Blandford, 2012. "The Determinants of HIV Treatment Costs in Resource Limited Settings," PLOS ONE, Public Library of Science, vol. 7(11), pages 1-9, November.
    13. Susan Cleary & Gavin Mooney & Di McIntyre, 2010. "Equity and efficiency in HIV‐treatment in South Africa: the contribution of mathematical programming to priority setting," Health Economics, John Wiley & Sons, Ltd., vol. 19(10), pages 1166-1180, October.
    14. Yazdan Yazdanpanah & Julian Perelman & Madeline A DiLorenzo & Joana Alves & Henrique Barros & Céu Mateus & João Pereira & Kamal Mansinho & Marion Robine & Ji-Eun Park & Eric L Ross & Elena Losina & Ro, 2013. "Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness," PLOS ONE, Public Library of Science, vol. 8(12), pages 1-1, December.
    15. Elliot Marseille & Mark J Giganti & Albert Mwango & Angela Chisembele-Taylor & Lloyd Mulenga & Mead Over & James G Kahn & Jeffrey S A Stringer, 2012. "Taking ART to Scale: Determinants of the Cost and Cost-Effectiveness of Antiretroviral Therapy in 45 Clinical Sites in Zambia," PLOS ONE, Public Library of Science, vol. 7(12), pages 1-13, December.
    16. David M. Eddy & William Hollingworth & J. Jaime Caro & Joel Tsevat & Kathryn M. McDonald & John B. Wong, 2012. "Model Transparency and Validation," Medical Decision Making, , vol. 32(5), pages 733-743, September.
    17. Kit Simpson & Alvin Strassburger & Walter Jones & Birgitta Dietz & Rukmini Rajagopalan, 2009. "Comparison of Markov Model and Discrete-Event Simulation Techniques for HIV," PharmacoEconomics, Springer, vol. 27(2), pages 159-165, February.
    18. Muhammad Hamza & Maryam A Idris & Musa B Maiyaki & Mohammed Lamorde & Jean-Philippe Chippaux & David A Warrell & Andreas Kuznik & Abdulrazaq G Habib, 2016. "Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 10(3), pages 1-16, March.
    19. Taghreed Adam & David B Evans & Bian Ying & Christopher J L Murray, 2014. "Variability in Costs across Hospital Wards. A Study of Chinese Hospitals," PLOS ONE, Public Library of Science, vol. 9(5), pages 1-8, May.
    20. Susan M. Cleary & Di McIntyre, 2009. "Affordability – the forgotten criterion in health‐care priority setting," Health Economics, John Wiley & Sons, Ltd., vol. 18(4), pages 373-375, April.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0012647. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.